Global Intravenous (IV) Fluid Monitoring Devices Market 2026-2030

Description

The global intravenous (IV) fluid monitoring devices market is forecasted to grow by USD 2729.7 mn during 2025-2030, accelerating at a CAGR of 8.6% during the forecast period. The report on the global intravenous (IV) fluid monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surging clinical need for error mitigation and real-time patient safety, accelerated integration of wireless internet of things and cloud analytics, expansion of outpatient infusion and home healthcare delivery models.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	8%
CAGR	8.6%
Incremental Value	$2729.7 mn

Technavio's global intravenous (IV) fluid monitoring devices market is segmented as below:

By End-User

Hospitals and clinics
ASCs
Home care

By Type

Desktop
Portable

By Technology

Smart devices
Traditional monitoring systems

Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the integration of AI and machine learning for predictive infusion safety as one of the prime reasons driving the global intravenous (IV) fluid monitoring devices market growth during the next few years. Also, expansion of closed-loop automatic infusion and flow regulation networks and rise in strategic joint ventures to strengthen manufacturing resilience and sensor infrastructure will lead to sizable demand in the market.

The report on the global intravenous (IV) fluid monitoring devices market covers the following areas:

Global intravenous (IV) fluid monitoring devices market sizing
Global intravenous (IV) fluid monitoring devices market forecast
Global intravenous (IV) fluid monitoring devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global intravenous (IV) fluid monitoring devices market vendors that include ACE Medical Devices Pvt Ltd, Akas Infusions, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., BPL MEDICAL TECHNOLOGIES, CODAN Medizinische Gerate GmbH, Eitan Medical Ltd., EVELABS TECHNOLOGIES Pvt. Ltd., FIVAmed Inc., Fresenius Kabi AG, IRadimed Corp., Micrel Medical Devices SA, MONIDOR Oy Ltd., Plenum Tech, Pronk Technologies Inc., Shenzhen Mindray Co. Ltd., Shift Labs Inc., Sino Medical Tech Co. Ltd., Terumo Corp., vTitan Corp. Pvt Ltd.. Also, the global intravenous (IV) fluid monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR43549

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Intravenous (IV) Fluid Monitoring Devices Market 2020 - 2024
- Historic Market Size - Data Table on Global Intravenous (IV) Fluid Monitoring Devices Market 2020 - 2024 ($ million)
5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Intravenous (IV) Fluid Monitoring Devices Market
6.2 Impact of geopolitical conflicts on Global Intravenous (IV) Fluid Monitoring Devices Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by End-user

8.1 Market segments
8.2 Comparison by End-user
8.3 Hospitals and clinics - Market size and forecast 2025-2030
8.4 ASCs - Market size and forecast 2025-2030
8.5 Home care - Market size and forecast 2025-2030
8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)

9 Market Segmentation by Type

9.1 Market segments
9.2 Comparison by Type
9.3 Desktop - Market size and forecast 2025-2030
9.4 Portable - Market size and forecast 2025-2030
9.5 Market opportunity by Type
- Market opportunity by Type ($ million)

10 Market Segmentation by Technology

10.1 Market segments
10.2 Comparison by Technology
10.3 Smart devices - Market size and forecast 2025-2030
10.4 Traditional monitoring systems - Market size and forecast 2025-2030
10.5 Market opportunity by Technology
- Market opportunity by Technology ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 Turkey - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Surging clinical need for error mitigation and real-time patient safety
- Accelerated integration of wireless internet of things and cloud analytics
- Expansion of outpatient infusion and home healthcare delivery models
13.2 Market challenges
- Technical limitations and high initial deployment expenditures
- Data security concerns and interoperability hurdles in hospital systems
- Market fragmentation and threats from counterfeit device proliferation
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Integration of AI and machine learning for predictive infusion safety
- Expansion of closed-loop automatic infusion and flow regulation networks
- Rise in strategic joint ventures to strengthen manufacturing resilience and sensor infrastructure

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 ACE Medical Devices Pvt Ltd
- ACE Medical Devices Pvt Ltd - Overview
- ACE Medical Devices Pvt Ltd - Product / Service
- ACE Medical Devices Pvt Ltd - Key offerings
- SWOT
15.5 Akas Infusions
- Akas Infusions - Overview
- Akas Infusions - Product / Service
- Akas Infusions - Key offerings
- SWOT
15.6 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings
- SWOT
15.7 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
15.8 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
15.9 BPL MEDICAL TECHNOLOGIES
- BPL MEDICAL TECHNOLOGIES - Overview
- BPL MEDICAL TECHNOLOGIES - Product / Service
- BPL MEDICAL TECHNOLOGIES - Key offerings
- SWOT
15.10 CODAN Medizinische Gerate GmbH
- CODAN Medizinische Gerate GmbH - Overview
- CODAN Medizinische Gerate GmbH - Product / Service
- CODAN Medizinische Gerate GmbH - Key offerings
- SWOT
15.11 Eitan Medical Ltd.
- Eitan Medical Ltd. - Overview
- Eitan Medical Ltd. - Product / Service
- Eitan Medical Ltd. - Key offerings
- SWOT
15.12 Fresenius Kabi AG
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings
- SWOT
15.13 IRadimed Corp.
- IRadimed Corp. - Overview
- IRadimed Corp. - Product / Service
- IRadimed Corp. - Key offerings
- SWOT
15.14 Micrel Medical Devices SA
- Micrel Medical Devices SA - Overview
- Micrel Medical Devices SA - Product / Service
- Micrel Medical Devices SA - Key offerings
- SWOT
15.15 Shenzhen Mindray Co. Ltd.
- Shenzhen Mindray Co. Ltd. - Overview
- Shenzhen Mindray Co. Ltd. - Business segments
- Shenzhen Mindray Co. Ltd. - Key offerings
- Shenzhen Mindray Co. Ltd. - Segment focus
- SWOT
15.16 Sino Medical Tech Co. Ltd.
- Sino Medical Tech Co. Ltd. - Overview
- Sino Medical Tech Co. Ltd. - Product / Service
- Sino Medical Tech Co. Ltd. - Key offerings
- SWOT
15.17 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
15.18 vTitan Corp. Pvt Ltd.
- vTitan Corp. Pvt Ltd. - Overview
- vTitan Corp. Pvt Ltd. - Product / Service
- vTitan Corp. Pvt Ltd. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations